NR0B1 augments sorafenib resistance in hepatocellular carcinoma through promoting autophagy and inhibiting apoptosis
Cancer Science · 2024-02 · 115 (2) · 465-476
DOI: 10.1111/cas.16029 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Science, online erschienen am 22.11.2023. Verfasst von Xiao Lan Tan und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Genetics and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China, Sichuan Science and Technology Program.
Abstract (Originalsprache)
NR0B1 is frequently activated in hepatocellular carcinoma (HCC). However, the role of NR0B1 is controversial in HCC. In this study, we observed that NR0B1 was an independent poor prognostic factor, negatively correlated with the overall survival of HCC and the relapse‐free survival of patients treated with sorafenib. Meanwhile, NR0B1 promoted the proliferation, migration, and invasion of HCC cells, inhibited sorafenib‐induced apoptosis, and elevated the IC50 of sorafenib in HCC cells. NR0B1 was further displayed to increase sorafenib‐induced autophagic vesicles and activate Beclin1/LC3‐II‐dependent autophagy pathway. Finally, NR0B1 was revealed to transcriptionally suppress GSK3β that restrains AMPK/mTOR‐driven autophagy and increases BAX‐mediated apoptosis. Collectively, our study uncovered that the ectopic expression of NR0B1 augmented sorafenib‐resistance in HCC cells by activating autophagy and inhibiting apoptosis. Our findings supported that NR0B1 was a detrimental factor for HCC prognosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Genetics and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China.
- Institute of Gerontology and Center for Geriatrics, Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China.
ORCID-Profile: Yun Qiang Liu
Förderung
- National Natural Science Foundation of China
- Sichuan Science and Technology Program
Zitieren
APA
Tan, X. L., Wang, Z., Liao, S., Yi, M., Tao, D., Zhang, X., Leng, X., Shi, J., Xie, S., Yang, Y., & Liu, Y. Q. (2024). NR0B1 augments sorafenib resistance in hepatocellular carcinoma through promoting autophagy and inhibiting apoptosis. Cancer Science, 115(2), 465-476. https://doi.org/10.1111/cas.16029
Vancouver
Tan XL, Wang Z, Liao S, Yi M, Tao D, Zhang X, et al. NR0B1 augments sorafenib resistance in hepatocellular carcinoma through promoting autophagy and inhibiting apoptosis. Cancer Science. 2024;115(2):465-476. doi:10.1111/cas.16029
BibTeX
@article{Tan2024,
author = {Tan, Xiao Lan and Wang, Zhaokun and Liao, Shunyao and Yi, Ming and Tao, Dachang and Zhang, Xinyue and Leng, Xiangyou and Shi, Jiaying and Xie, Shengyu and Yang, Yuan and Liu, Yun Qiang},
title = {NR0B1 augments sorafenib resistance in hepatocellular carcinoma through promoting autophagy and inhibiting apoptosis},
journal = {Cancer Science},
year = {2024},
volume = {115},
number = {2},
pages = {465--476},
doi = {10.1111/cas.16029}
}
EUVIMED